Methylprednisolone sodium succinate and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone sodium succinate and Repaglinide. Common interactions include acne among females and angioedema among males.

The phase IV clinical study analyzes what interactions people who take Methylprednisolone sodium succinate and Repaglinide have. It is created by eHealthMe based on reports of 19 people who take Methylprednisolone sodium succinate and Repaglinide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

19 people who take Methylprednisolone sodium succinate and Repaglinide together, and have interactions are studied.

What is Methylprednisolone sodium succinate?

Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 13,090 Methylprednisolone sodium succinate users for its effectiveness, alternative drugs and more.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 6,900 Repaglinide users for its effectiveness, alternative drugs and more.

Number of Methylprednisolone sodium succinate and Repaglinide reports submitted per year:

Common Methylprednisolone Sodium Succinate and Repaglinide drug interactions by gender *:

female:

Acne
Balance disorder
Blood glucose increased
Bronchitis
Burning sensation
Diarrhoea
Erythema
Flushing
Hypersensitivity
Infusion site pain

male:

Angioedema
Drug ineffective
Dysphagia
Swelling face
Swollen tongue
Swelling
Local swelling
Encephalopathy
Infection
Pneumonitis

Common Methylprednisolone Sodium Succinate and Repaglinide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Acne
Balance disorder
Blood glucose increased
Bronchitis
Burning sensation
Diarrhoea
Erythema
Flushing
Hypersensitivity
Infusion site pain

40-49:

n/a

50-59:

n/a

60+:

Angioedema
Drug ineffective
Local swelling
Encephalopathy
Infection
Pneumonitis
Dysphagia
Swelling face
Swollen tongue
Swelling

Common conditions people have *:

High Blood Pressure: 7 people, 36.84%
Angioedema (rapid swelling of the dermis): 6 people, 31.58%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 21.05%
Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 10.53%
Type 2 Diabetes: 2 people, 10.53%
Sleep Disorder: 2 people, 10.53%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 10.53%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 1 person, 5.26%
Neuroendocrine Tumor: 1 person, 5.26%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone sodium succinate and Repaglinide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.